Literature DB >> 20339359

Effect of weight loss on high-molecular weight adiponectin in obese children.

Gabriel Á Martos-Moreno1, Vicente Barrios, Guillermo Martínez, Federico Hawkins, Jesús Argente.   

Abstract

Our aim was to determine the influence of weight reduction on total (T-) and high-molecular weight (HMW-) adiponectin in obese (OB) prepubertal children. Seventy OB prepubertal white patients were followed for 18 months and studied after reducing their BMI by 1 (n = 51) and 2 standard deviation scores (SDS) (n = 21) under conservative treatment, and 6 months after achieving weight loss (n = 44). Body composition dual-energy X-ray absorptiometry (DXA) and serum levels of T- and HMW-adiponectin, resistin, leptin, leptin soluble receptor (sOB-R), tumoral necrosis factor-α and interleukin-6 were determined. The control group consisted of 61 healthy prepubertal children. At diagnosis T-adiponectin was higher (P < 0.01; confidence interval (+0.04) - (+0.15)) and HMW-adiponectin lower (P < 0.001; confidence interval (-0.45) - (-0.21)) in OB children than in controls. A reduction in body fat increased T- and HMW-adiponectin and sOB-R (all P < 0.001) and decreased leptin (P < 0.001) and interleukin-6 levels (P < 0.05). After 6 months of sustained weight reduction a decrease in tumoral necrosis factor-α (P < 0.01) occurred, whereas weight recovery increased leptin (P < 0.001) and decreased T-adiponectin (P < 0.05). HMW-adiponectin levels negatively correlated with homeostasis model assessment (HOMA) index and BMI in the whole cohort (both P < 0.001), as did T-adiponectin levels and HOMA index in OB patients (P < 0.01), but neither T- nor HMW-adiponectin correlated with body fat content (BFC) in OB children. We conclude that the impairment of T- and HMW-adiponectin levels in childhood obesity is different to that in elder OB patients, showing closer relationship with carbohydrate metabolism parameters than with BFC, but increasing their levels after weight loss and in association with metabolic improvement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339359     DOI: 10.1038/oby.2010.68

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  15 in total

Review 1.  [Adipokines in healthy and obese children].

Authors:  G A Martos-Moreno; J J Kopchick; J Argente
Journal:  An Pediatr (Barc)       Date:  2012-11-24       Impact factor: 1.500

Review 2.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

3.  Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children.

Authors:  G Á Martos-Moreno; A Mastrangelo; V Barrios; A García; J A Chowen; F J Rupérez; C Barbas; J Argente
Journal:  Int J Obes (Lond)       Date:  2017-06-07       Impact factor: 5.095

Review 4.  Principles and pitfalls in the differential diagnosis and management of childhood obesities.

Authors:  Gabriel Á Martos-Moreno; Vicente Barrios; María T Muñoz-Calvo; Jesús Pozo; Julie A Chowen; Jesús Argente
Journal:  Adv Nutr       Date:  2014-05-14       Impact factor: 8.701

5.  Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren.

Authors:  Giuseppe Murdolo; Bettina Nowotny; Federica Celi; Miranda Donati; Vittorio Bini; Francesco Papi; Gabi Gornitzka; Serena Castellani; Michael Roden; Adriano Falorni; Christian Herder; Alberto Falorni
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

6.  Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions.

Authors:  Gillian E Walker; Roberta Ricotti; Marta Roccio; Stefania Moia; Simonetta Bellone; Flavia Prodam; Gianni Bona
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

Review 7.  Adiponectin as a potential biomarker of vascular disease.

Authors:  Mehrangiz Ebrahimi-Mamaeghani; Somayeh Mohammadi; Seyed Rafie Arefhosseini; Parviz Fallah; Zahra Bazi
Journal:  Vasc Health Risk Manag       Date:  2015-01-16

8.  Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations.

Authors:  A Mastrangelo; G Á Martos-Moreno; A García; V Barrios; F J Rupérez; J A Chowen; C Barbas; J Argente
Journal:  Int J Obes (Lond)       Date:  2016-05-10       Impact factor: 5.095

9.  Adiponectin in eutrophic and obese children as a biomarker to predict metabolic syndrome and each of its components.

Authors:  Miguel Klünder-Klünder; Samuel Flores-Huerta; Rebeca García-Macedo; Jesús Peralta-Romero; Miguel Cruz
Journal:  BMC Public Health       Date:  2013-01-30       Impact factor: 3.295

10.  Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children.

Authors:  Gabriel Á Martos-Moreno; Lucila Sackmann-Sala; Vicente Barrios; Darlene E Berrymann; Shigeru Okada; Jesús Argente; John J Kopchick
Journal:  Int J Pediatr Endocrinol       Date:  2014-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.